SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 114 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $367,000 | +52.3% | 8,089 | +106.9% | 0.06% | +29.8% |
Q3 2016 | $241,000 | -89.3% | 3,910 | -86.5% | 0.05% | -2.1% |
Q4 2014 | $2,244,000 | +518.2% | 29,040 | +77.9% | 0.05% | -12.7% |
Q3 2014 | $363,000 | -99.9% | 16,320 | -53.4% | 0.06% | -55.3% |
Q2 2014 | $521,846,000 | +271694.8% | 35,000 | +337.5% | 0.12% | +112.1% |
Q1 2014 | $192,000 | +17.8% | 8,000 | 0.0% | 0.06% | +11.5% |
Q4 2013 | $163,000 | +81.1% | 8,000 | +236.8% | 0.05% | +67.7% |
Q2 2013 | $90,000 | – | 2,375 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |